In the present study we propose that SB3 can affect the behavior of liver cancer cells by increasing both HIF-1α, at transcription level through a redox-dependent mechanism, and HIF-2α protein levels by direct and selective NEDDylation/stabilization of HIF-2α, then resulting in up-regulation of related target genes. This evidence concerns the gene HIF1A and liver cancer.